Results of pilot testing demonstrate high usability and strong potential to expand equitable access to asthma self-management education FAIRFAX, Va., March 27, 2026 /PRNewswire/ -- Allergy & Asthma Network, a national leader in patient-centered research and education, and Blue Marble Health, a digital health technology company, today announced the publication of new research in The Journal of Allergy and Clinical Immunology in Practice (JACI: In Practice) highlighting the development and usabil

Raised over $20 million in gross proceeds in 2025 and held $11.9 million in cash and cash equivalents as of December 31, 2025, with a cash runway into the second quarter of 2027 IT-01 Study manuscript of INT230-6 used alone in 64 refractory metastatic cancer patients published in the Lancet's journal eBioMedicine, including data for disease control rate, overall survival, immune activation, abscopal effects, tumor necrosis, dose ranging, and safety Favorable efficacy and safety reported in a sma

A higher standard of wound care will greatly improve overall patient care and facility management. Developing and implementing industry standards of quality in wound care in long-term care will lead to faster healing, greater patient satisfaction & improved profitability for health care facilities.” — David Navazio - President & CEO, Gentell, Inc.l YARDLEY, PA, UNITED STATES, March 27, 2026 / EINPresswire.com / -- Wounds are a major challenge in long-term care. Studies analyzing resident senior

Comprehensive guide on ICH Q1A(R2) storage conditions, testing intervals, stability data for IND/NDA submission, and designing FDA-compliant stability programs. IRVINE, CA, UNITED STATES, March 27, 2026 / EINPresswire.com / -- Qalitex Laboratories, an ISO 17025-accredited third-party testing laboratory with ICH-qualified stability testing capabilities serving pharmaceutical drug developers and CROs across North America, today released expert guidance on ICH Q1A(R2) pharmaceutical stability testi

Accelerated by the recruitment of world-class physicians, efforts begin with liver and kidney transplants Dr. Aaron Ahearn joins Hoag's Digestive Health Institute team as surgical director of Hoag's emerging liver and kidney transplant program NEWPORT BEACH, Calif., March 27, 2026 /PRNewswire/ -- Hoag today announced a key milestone in its effort to establish a comprehensive organ transplant center with the recruitment of Aaron Ahearn, M.D., Ph.D., as surgical director of its emerging liver and

SAN FRANCISCO--(BUSINESS WIRE)--Mochi Health, the telehealth marketplace transforming how patients access affordable, transparent care, announced its participation as a Premiere Sponsor of the Livelong Women's Health Summit, taking place April 17-18 in San Francisco. Founder and CEO Myra Ahmad, M.D will represent the company as a featured speaker and roundtable host. "We're excited to bring Mochi's approach to the Livelong Summit and have honest conversations about what GLP-1 treatments can and

Gradient Toxicologist Lindsey Borton has received the Best Published Paper Award from the Medical Device and Combination Product Specialty Section of the Society of Toxicology. BOSTON, March 27, 2026 /PRNewswire/ -- Gradient announces that Principal Toxicologist Lindsey Borton and Medtronic Sr. Distinguished Toxicologist Kelly Coleman have been awarded Best Published Paper by the Medical Device and Combination Product Specialty Section of the Society of Toxicology. This award recognizes "outstan

Long-term subcutaneous SPEVIGO ® (spesolimab-sbzo) treatment reduced flare frequency in patients with generalized pustular psoriasis (GPP), with nearly 75% experiencing no flares over three years. 1 Rapid flare control was observed, with 50% of patients achieving a GPPGA pustulation subscore of 0 at Week 1 with intravenous SPEVIGO. 2 MADISON, N.J.--(BUSINESS WIRE)--LEO Pharma A/S, a global leader in medical dermatology, today announced new long-term results from EFFISAYIL® ON, an ongoing five-ye

Localized oxygen generation supports dense clusters of drug-producing cells in a compact implant HOUSTON, March 27, 2026 /PRNewswire/ -- Implanting living cells as long-term drug producers could transform treatment for numerous diseases, but it is difficult to house the tiny workers in quantities high enough to ensure dosage needs are met while also keeping the cells alive and thriving. Researchers at Rice University and collaborators at Carnegie Mellon University and Northwestern University hav

Therapeutic Plasma Exchange for Complex Medical Diagnoses DENVER, March 27, 2026 /PRNewswire/ -- ThriveMD is proud to announce the addition of Therapeutic Plasma Exchange (TPE) to its suite of services, offering patients one of the most exciting longevity interventions available today. Continue Reading Procedures are performed at our Centennial office by licensed providers. Sessions last 3-4 hours. TPE, an innovative, targeted procedure that filters and removes disease-causing components from pl